Industry Reports

In a bid to develop contrast agents with reduced renal toxicity, Ligand Pharmaceuticals set to initiate a program to develop contrast agents with lessened renal toxicity. Enabling usage…
Read More...

Pandion Therapeutics declared the completion of a $58 million Series A financing that will be utilized to further its drug programs for autoimmune and inflammatory diseases in addition…
Read More...

U.S FDA clears OBI Pharma's investigational new drug (IND) application for a Phase 1 study of a monoclonal antibody cancer immunotherapy targeting Globo H, a glycolipid antigen…
Read More...

BioLineRx, committed to oncology and immunology declared partial results from the monotherapy portion of BL-8040's Phase 2a COMBAT study. The study reveals that BL-8040 increases…
Read More...

APRINOIA Therapeutics into  tau, alpha-synuclein, and novel targets for neurodegenerative diseases declared the completion of its US$11.1 million Series B round to finance preclinical…
Read More...

Ophthalmic Pharmaceutical Company, Aerie Pharmaceuticals that seeks to treat patients with open-angle glaucoma and other diseases of the eye declared the appointment of Nils Hauptmann…
Read More...

Developer of surgical implants for treating distal extremity pathology, Centric Medical asserted that the U.S FDA has granted 510 (k) clearance to the Cannulated Screw Internal Fixation…
Read More...

Lustgarten Foundation alleges $22 million funding in 2017 as part of its mission to invest an unprecedented $40 million by the end of 2018. In a bid to advanced pancreatic Cancer…
Read More...

Genomic and Medical research knowledge base powered by the blockchain and owned by its community, Luna DNA declared Dawn Barry as president. Barry will be held accountable for leading…
Read More...

Following the league of leading in the markets of  clinical research organizations, Optimapharm obtained Czech CRO company MKS research. Following the acquisition , Optimapharm will…
Read More...

It is noteworthy that Ligand Pharmaceuticals entered into license agreement with Glenmark Pharmaceuticals to use Ligand's OmniAb platform including Omnichicken, Omnirat, OmniMouse and…
Read More...

In a bid to offer qualitative radiation therapy and cancer care services, Alliance healthcare services ventures into a stock purchasing agreement with e+CancerCare in order to function…
Read More...

The network of independent health systems based out of Arkansas, Missouri and Texas collaborate with Vizient for comprehensive sourcing, improvement of performance as well as services…
Read More...

Miraca Life sciences declared that it intends to change its name to inform Diagnostics with effect from immediate Avista Capital partners had acquired the company in November. The new…
Read More...

TAI diagnostics that oversees the health of transplanted organs announced the final closing of $10 million Series A preferred equity financing that will aid ongoing research and…
Read More...

A generic pharmaceutical company Leading Pharma, LLC that manufactures and distributes drug chains, wholesalers declared that it became a successful recipient of $ 40 million of growth…
Read More...

In a bid to replace its expired base shelf prospectus and corresponding shelf registration statement on form F-10, Aurinia Pharmaceuticals files new tentative base shelf prospectus …
Read More...

Advanced precision medicine CIRCULOGENE through its molecular genetics testing enters into an international licensing agreement with turkey based CIRCULOGENE Saglik. As per the terms…
Read More...

CanniMed Therapeutics Inc’s wholly owned subsidiary Sub Terra LLC moves to produce and process medical cannabis through its State of Michigan licenses application. The company has…
Read More...

Medicure International has acquired an exclusive license to sell and market PREXXARTAN (valsartan) oral solution in the United States and its territories from Carmel Biosciences, Inc.…
Read More...